Subscribe to these results:

Upcoming Workshops

  1. Register
  2. Register
  3. Register

Past Workshops

  1. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
  2. Non-Hodgkin Lymphoma: Current Treatment Progress
  3. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
  4. Diffuse Large B-Cell Lymphoma (DLBCL): Treatment Updates
  5. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
  6. What’s New In Precision Medicine
  7. Highlights from the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting - "Advancing Equitable Cancer Care Through Innovation"Part II of Highlights from the 2022 ASCO Annual Meeting
  8. Update On Marginal Zone Lymphoma (MZL)
  9. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
  10. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
  11. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
  12. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
  13. Coping with the Stresses of Caregiving When Your Loved One Has Mantle Cell Lymphoma (MCL)Part II of Living with Mantle Cell Lymphoma (MCL)
  14. Mantle Cell Lymphoma: Treatment UpdatePart I of Living with Mantle Cell Lymphoma (MCL)
  15. Follicular Lymphoma: Treatment Progress
  16. Diffuse Large B-Cell Lymphoma (DLBCL) Updates
  17. Marginal Zone Lymphoma (MZL): Treatment Updates
  18. What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
  19. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
  20. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual MeetingPart II of Equity. Every Patient. Every Day. Everywhere.
  21. Transplantation as a Treatment Option for Blood Cancers
  22. Update on Marginal Zone Lymphoma (MZL)
  23. What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
  24. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
  25. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
  26. Update on Diffuse Large B-Cell Lymphoma (DLBCL)
  27. Update on CAR T-Cell Therapies
  28. Coping with the Stresses of Caregiving When Your Loved One Has Mantle Cell Lymphoma (MCL)Part II of Living with Mantle Cell Lymphoma
  29. Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
  30. Treatment Update on Mantle Cell Lymphoma (MCL)Part I of Living with Mantle Cell Lymphoma
  31. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
  32. Progress in the Treatment of Follicular Lymphoma
  33. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
  34. Update on Diffuse Large B-Cell Lymphoma (DLBCL)
  35. New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
  36. What’s New in the Treatment of Hodgkin Lymphoma
  37. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress TogetherPart II of Your Guide to the Latest Cancer Research and Treatment
  38. Treatment Update on Mantle Cell Lymphoma (MCL)
  39. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
  40. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
  41. Taking Your Blood Cancer Treatment on Schedule
  42. The Latest News in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
  43. Caregiving for Your Loved One with Mantle Cell Lymphoma
  44. Update on Diffuse Large B-Cell Lymphoma
  45. For Caregivers: Coping with a Loved One’s Waldenstrom’s Macroglobulinemia (WM)
  46. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
  47. The Emerging Role of Immunotherapy in the Treatment of Lymphoma
Back to Top
Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.